Brief: Cassava Sciences Inc - On Dec 15, FDA Places Full Clinical Hold On Cassava's Trial - SEC Filing
18/12/2025 23:28
Dec 18 (Reuters) - Cassava Sciences Inc SAVA.O: CASSAVA SCIENCES INC - ON DEC 15, FDA PLACES FULL CLINICAL HOLD ON CASSAVA'S TRIAL - SEC FILING CASSAVA SCIENCES: NOT EXPECTED TO INITIATE PROOF-OF-CONCEPT CLINICAL TRIAL FOR SIMUFILAM IN TSC-RELATED EPILEPSY IN H1 2026 AS PREVIOUSLY DISCLOSED Source text: [ID:n0001437749-25-038313] Further company coverage: SAVA.O ((((Reuters.Briefs@thomsonreuters.com;));))